If you are looking into retatrutide in Canada for a research programme, the first thing to settle is what you are actually able to buy. Retatrutide (development code LY3437943) is an investigational triple-receptor peptide that no regulator, Health Canada included, has authorised as a drug. What Canadian laboratories can source is research-grade material: a synthetic reagent for in-vitro and analytical work. This page sets out the Canadian status, the chemistry a buyer needs to know, and the documents and handling practices that matter when a lab orders retatrutide in volume.
Bulk Peptides is a Vancouver-based supplier of research materials to laboratories across Canada. This is an information page; it contains no product listings and nothing on it relates to use in people or animals.
Retatrutide’s status in Canada at a glance
- No Canadian authorisation. Retatrutide has not received a Notice of Compliance and has no Drug Identification Number, so it cannot be sold, prescribed or dispensed as a medicine anywhere in Canada.
- No Canadian filing on record. It is absent from Health Canada’s published list of new drug submissions under review (the list current to the end of August 2026).
- Not authorised abroad either. No country has approved it. The developer has said publicly that it plans a first United States filing in the first quarter of 2027.
- Research supply only. Material sold to labs is a chemical reagent with no pharmaceutical quality claims: no GMP manufacture, no sterility or endotoxin assurance, no directions for use.
The molecule, from a buyer’s point of view
Retatrutide is a single peptide chain of 39 residues designed to activate three class B G-protein-coupled receptors: the GIP receptor, the glucagon-like peptide-1 receptor and the glucagon receptor. For a purchasing or QC lead, three structural facts matter more than the pharmacology:
- It is long. Thirty-nine coupling steps give many opportunities for a missing or duplicated residue, and those errors change the mass by only a few percent of a molecule this size.
- It is lipidated. A long fatty diacid is attached through a linker to a lysine side chain. The lipid dominates how the molecule behaves on a reversed-phase HPLC column, so impurities that carry the same lipid can hide under or beside the main peak.
- It contains non-coded residues. Aminoisobutyric acid (Aib) and an alpha-methylated leucine are built into the sequence, which complicates fragmentation-based sequence confirmation.
The online nickname “GLP-3” is not a scientific or regulatory name and should not appear on a specification. Our separate article, Retatrutide analytical guide, covers the structure and testing in more depth.
Documents to insist on before a bulk retatrutide order
For a single vial, a thin certificate is an irritation. For a multi-vial order that feeds weeks of assays, it is a genuine risk, because every result downstream inherits whatever is in the vial. A sensible minimum for retatrutide is:
| Document or result | Why it matters for this molecule |
|---|---|
| HPLC chromatogram with integration shown | Lets you see shoulders and late-eluting lipid-bearing impurities, not just a headline percentage. |
| Mass spectrometry result for the intact peptide | The decisive identity check. A deletion or incomplete deprotection shows up as a mass difference that HPLC may not separate. |
| Name of the testing laboratory | Independent third-party testing carries more weight than an unexplained in-house figure. |
| A way to tie the certificate to your vials | Our products are third-party tested for purity by HPLC; certificates are published for some products, and vials are matched to their certificate by cap and crimp colour. |
| Nominal versus net content | Label mass includes counter-ion and water. Net peptide content is lower, which changes every concentration you calculate. |
If you order across several months, keep each certificate with the receiving record for that shipment, and compare the chromatograms from one order to the next. A shift in the impurity profile between two deliveries is exactly the kind of lot-to-lot difference that can quietly change assay results. Our notes on tracking lot-to-lot variation and reading a certificate of analysis section by section go further.
Receiving and storing retatrutide in a Canadian lab
Research-grade retatrutide ships as a lyophilised solid. Dry peptide tolerates brief temperature swings far better than a solution does, but Canadian logistics still deserve a plan. Orders dispatched from within Canada skip customs clearance, duty and brokerage, which removes the most unpredictable part of the journey. Winter depots and summer delivery vans are the remaining variables.
- Inspect cartons on arrival and note any damage or wet packaging before opening.
- Record the cap and crimp colours of each vial alongside the date received, before any vial is opened.
- Move the stock to refrigerated storage at 2–8 °C, away from light, in the original cartons.
- Allow a vial to reach room temperature before opening it, so condensation does not form on the cold powder.
- For large stocks, keep unopened vials together and open one at a time, so a single handling error does not touch the whole order.
More detail is in receiving a peptide shipment and storing lyophilised peptide stock.
Comparing retatrutide offers fairly
Because retatrutide has no Canadian retail or pharmacy price, research suppliers set their own per-vial prices, and quotes can look very different. The comparison that actually means something is cost per milligram of confirmed peptide: take the vial price, divide by the net peptide content rather than the label mass, and discount any offer that cannot show a mass spectrometry identity result. At Bulk Peptides, volume pricing is mix-and-match, so every vial in an order counts toward the volume break rather than each product being counted separately. Our guide to comparing true cost per milligram walks through the arithmetic.
Retatrutide Canada FAQ
Can I buy retatrutide in Canada?
Not as a medicine, since there is no authorised product. Laboratories can source research-grade retatrutide from Canadian research suppliers for in-vitro and analytical research only.
Is retatrutide approved by Health Canada?
No. It has no Notice of Compliance and no DIN, and no Canadian submission appears on the public list of submissions under review.
Why do some sites call retatrutide “GLP-3”?
It is an internet nickname that plays on its three receptor targets. There is no GLP-3 hormone, and the term has no scientific or regulatory standing.
What purity should research-grade retatrutide have?
Look past the percentage. For a 39-residue lipidated peptide, a mass spectrometry result confirming the intact molecule tells you more than a high HPLC area figure on its own, because some impurities co-elute with the main peak.
How should retatrutide be stored?
As a dry, lyophilised solid in the fridge at 2–8 °C, protected from light and moisture, in the original sealed vial until needed.
Does a bulk order ship across Canada?
Yes. Orders are dispatched from within Canada to every province and territory, so there is no customs step for Canadian delivery.
Bulk Peptides supplies research materials to qualified laboratories for in-vitro and analytical research only. Retatrutide is an investigational compound with no Canadian market authorisation for human use. This page is not medical or legal advice and does not describe or support use in people or animals.
